WHO ICTRP trial
Characterization of "zinc finger E-box–binding homeobox 1 (ZEB1)"-mediated…
DRKS00004577 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00004577 |
|---|---|
| Public title | Characterization of "zinc finger E-box–binding homeobox 1 (ZEB1)"-mediated epithelial-mesenchymal transition (EMT) in glioblastoma (GBM) with respect to molecular subtypes |
| Scientific title | Characterization of "zinc finger E-box–binding homeobox 1 (ZEB1)"-mediated epithelial-mesenchymal transition (EMT) in glioblastoma (GBM) with respect to molecular subtypes |
| Primary sponsor | Charité Universitätsmedizin Berlin Klinik für Neurologie |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | Glioblastoma multiforme C71;Malignant neoplasm of brain |
| Interventions | Group 1: A library of primary glioma cell lines will be generated. Clinical and radiological (follow-up) data will be correlated to the molecular properties of the tumor. |
| Registration date | Nov 30, 2012 |
| Target size | 40 |
| Secondary IDs | U1111-1137-4400 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: